CausalSentinel

Protein Dossier — ANG (Angiogenin)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: B37 Candidiasis 0.485 0.14 5.53e-04 Wald ratio 1 cis NA
Microalbuminuria 0.124 0.0397 0.00178 Wald ratio 1 cis NA
Non-cancer illness code self-reported: polio or poliomyelitis 0.358 0.127 0.00484 Wald ratio 1 cis NA
Serum cystatin C (eGFRcys) -0.00967 0.00372 0.00932 Wald ratio 1 cis NA
Potassium in urine -0.0123 0.00474 0.0095 Wald ratio 1 cis NA
Non-cancer illness code self-reported: vitiligo 0.471 0.184 0.0105 Wald ratio 1 cis NA
Eye problems or disorders: Glaucoma 0.088 0.0357 0.0136 Wald ratio 1 cis NA
Hip osteoarthritis 0.118 0.0545 0.0302 Wald ratio 1 cis NA
Systemic lupus erythematosus -0.183 0.0884 0.0381 Wald ratio 1 cis NA
Diagnoses - main ICD10: R07 Pain in throat and chest -0.0438 0.0218 0.0443 Wald ratio 1 cis NA
Neo-extraversion -0.297 0.155 0.0555 Wald ratio 1 cis NA
Vascular or heart problems diagnosed by doctor: Angina -0.0528 0.0276 0.0562 Wald ratio 1 cis NA
…and 100 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4874_3_1 Angiogenin Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

38 association rows across 15 traits (34 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating ANG levels 1e-1158 rs10220701 5 GCST90860430 no MR -> candidate analysis
ANG/F9 protein level ratio 6e-1118 rs17114671 1 GCST90313259 no MR -> candidate analysis
Angiogenin levels 3e-452 rs11851044 11 GCST90246501 no MR -> candidate analysis
Serum levels of protein ANG 2e-86 rs36071889 2 GCST90088789 no MR -> candidate analysis
ANG protein levels 1e-69 rs552960263 4 GCST90468307 no MR -> candidate analysis
RNASE4 protein levels 1e-63 rs780392419 3 GCST90470478 no MR -> candidate analysis
Ribonuclease 4 levels 8e-45 rs4470055 3 GCST90426424 no MR -> candidate analysis
Ribonuclease 4 levels (RNASE4.5644.60.3) 1e-36 rs184297073 2 GCST90242666 no MR -> candidate analysis
Blood protein levels 1e-18 rs1888560 1 GCST006585 no MR -> candidate analysis
Protein quantitative trait loci 1e-17 rs34121942 1 GCST010900 no MR -> candidate analysis
Ribonuclease 4 level in Chronic kidney disease with hyperten 4e-15 rs944438 1 GCST90238008 no MR -> candidate analysis
Tyrosine-protein phosphatase non-receptor type substrate 1 p 9e-9 rs17516133 1 GCST90439340 no MR -> candidate analysis
…and 3 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 643 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
amyotrophic lateral sclerosis 0.917 established (curated) no MR -> candidate analysis
frontotemporal dementia 0.426 established (curated) no MR -> candidate analysis
hereditary disease 0.306 established (curated) no MR -> candidate analysis
frontotemporal dementia with motor neuron disease 0.195 established (curated) no MR -> candidate analysis
schizophrenia 0.116 common-variant locus MR: beta=0.0187, p=0.366 (cis)

Of the 5 rows above, 4 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 8 known modulators (Angiopoietin-2)
gnomAD constraint pLI=NA, LOEUF=NA — Constraint metrics missing; LoF tolerance cannot be judged.
GWAS Catalog 108 unique SNPs / 225 rows
ClinVar 158 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance